Inspire Medical Systems, Inc. (FRA:2DR)
49.63
-0.89 (-1.76%)
Last updated: Feb 20, 2026, 3:49 PM CET
Inspire Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 104.81 | 150.15 | 185.54 | 441.59 | 214.47 |
Short-Term Investments | 203.46 | 295.4 | 274.84 | 9.82 | - |
Cash & Short-Term Investments | 308.27 | 445.55 | 460.38 | 451.41 | 214.47 |
Cash Growth | -30.81% | -3.22% | 1.98% | 110.48% | -8.49% |
Receivables | 119.69 | 93.07 | 89.88 | 61.23 | 34.18 |
Inventory | 145.29 | 80.12 | 33.89 | 11.89 | 17.23 |
Prepaid Expenses | 10.4 | 12.07 | 9.6 | 5.51 | 2.66 |
Total Current Assets | 583.65 | 630.81 | 593.74 | 530.03 | 268.54 |
Property, Plant & Equipment | 121.4 | 95.24 | 62.65 | 24.13 | 16.41 |
Long-Term Investments | 112.73 | 81.6 | 19.54 | 10.5 | 9.94 |
Long-Term Deferred Tax Assets | 88.67 | 0.01 | - | - | - |
Other Long-Term Assets | 0.86 | 0.73 | 0.88 | 0.22 | 0.2 |
Total Assets | 907.32 | 808.38 | 676.81 | 564.88 | 295.08 |
Accounts Payable | 36.57 | 38.69 | 38.84 | 26.85 | 11.67 |
Accrued Expenses | 54.29 | 45.52 | 37.59 | 32.08 | 19.67 |
Current Portion of Long-Term Debt | - | - | - | - | 9.19 |
Current Portion of Leases | 2.16 | 1.75 | - | 1.34 | 0.31 |
Current Income Taxes Payable | 2.45 | 1.61 | 0.58 | - | - |
Other Current Liabilities | 0.59 | 0.93 | 1.1 | 0.92 | 0.47 |
Total Current Liabilities | 96.06 | 88.5 | 78.11 | 61.19 | 41.31 |
Long-Term Debt | - | - | - | - | 15.8 |
Long-Term Leases | 30 | 30.04 | 24.85 | 7.54 | 8.8 |
Other Long-Term Liabilities | 0.1 | 0.15 | 1.35 | 0.15 | 0.13 |
Total Liabilities | 126.16 | 118.69 | 104.3 | 68.87 | 66.04 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-In Capital | 927.16 | 981.04 | 917.11 | 820.34 | 508.47 |
Retained Earnings | -146.49 | -291.91 | -345.42 | -324.27 | -279.39 |
Comprehensive Income & Other | 0.46 | 0.54 | 0.8 | -0.09 | -0.06 |
Total Common Equity | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Shareholders' Equity | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Total Liabilities & Equity | 907.32 | 808.38 | 676.81 | 564.88 | 295.08 |
Total Debt | 32.16 | 31.79 | 24.85 | 8.87 | 34.1 |
Net Cash (Debt) | 276.11 | 413.75 | 435.53 | 442.54 | 180.37 |
Net Cash Growth | -33.27% | -5.00% | -1.58% | 145.35% | -11.46% |
Net Cash Per Share | 9.28 | 13.55 | 14.86 | 15.76 | 6.62 |
Filing Date Shares Outstanding | 28.59 | 29.67 | 29.59 | 29.05 | 27.53 |
Total Common Shares Outstanding | 28.58 | 29.74 | 29.56 | 29.01 | 27.42 |
Working Capital | 487.6 | 542.31 | 515.63 | 468.85 | 227.23 |
Book Value Per Share | 27.33 | 23.19 | 19.37 | 17.10 | 8.35 |
Tangible Book Value | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Tangible Book Value Per Share | 27.33 | 23.19 | 19.37 | 17.10 | 8.35 |
Machinery | 54.21 | 34.1 | 9.42 | 8.24 | 6.08 |
Construction In Progress | 24.38 | 24.98 | 33.21 | 11.86 | 5.18 |
Leasehold Improvements | 11.77 | 10.06 | 2.36 | 2.06 | 0.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.